IL234228B - Compositions of glp-1 peptides and preparation thereof - Google Patents

Compositions of glp-1 peptides and preparation thereof

Info

Publication number
IL234228B
IL234228B IL234228A IL23422814A IL234228B IL 234228 B IL234228 B IL 234228B IL 234228 A IL234228 A IL 234228A IL 23422814 A IL23422814 A IL 23422814A IL 234228 B IL234228 B IL 234228B
Authority
IL
Israel
Prior art keywords
glp
peptides
compositions
preparation
Prior art date
Application number
IL234228A
Other languages
Hebrew (he)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/055362 external-priority patent/WO2013139694A1/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL234228B publication Critical patent/IL234228B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL234228A 2012-03-22 2014-08-21 Compositions of glp-1 peptides and preparation thereof IL234228B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12160743 2012-03-22
US201361748840P 2013-01-04 2013-01-04
EP13153459 2013-01-31
PCT/EP2013/055362 WO2013139694A1 (en) 2012-03-22 2013-03-15 Compositions of glp-1 peptides and preparation thereof

Publications (1)

Publication Number Publication Date
IL234228B true IL234228B (en) 2019-03-31

Family

ID=65910839

Family Applications (1)

Application Number Title Priority Date Filing Date
IL234228A IL234228B (en) 2012-03-22 2014-08-21 Compositions of glp-1 peptides and preparation thereof

Country Status (4)

Country Link
KR (1) KR102266299B1 (en)
CY (1) CY1120767T1 (en)
IL (1) IL234228B (en)
PT (1) PT2827885T (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372629B (en) * 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
WO2008003050A2 (en) * 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
US20090124639A1 (en) * 2007-11-06 2009-05-14 Emisphere Technologies Inc. valacyclovir formulations
NZ591497A (en) * 2008-08-18 2012-11-30 Entera Bio Ltd A compositions comprising a protein, a protease inhibitor and N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC) or N-(10[2-hydroxybenzoyl]amino)decanoate (SNAD) for diabetes mellitus treatment
NZ602921A (en) * 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
HUE062740T2 (en) * 2012-03-22 2023-12-28 Novo Nordisk As Compositions of glp-1 peptides and preparation thereof

Also Published As

Publication number Publication date
PT2827885T (en) 2018-11-05
KR20200013078A (en) 2020-02-05
KR102266299B1 (en) 2021-06-18
CY1120767T1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
HRP20181447T1 (en) Compositions of glp-1 peptides and preparation thereof
HK1207001A1 (en) Immunostimulatory compositions and methods of use thereof
EP2906212A4 (en) Therapeutic compounds and compositions
HRP20180633T1 (en) Methods for the preparation and delivery of fuel compositions
HK1215793A1 (en) Lyophilized formulation of tat-nr2b9c tat-nr2b9c
HK1203161A1 (en) Peptides and methods of using same
EP2897639A4 (en) Improved vaccine compositions and methods of use
HK1203149A1 (en) Novel dosage form and formulation of abediterol
EP2775831A4 (en) Pharmaceutical compositions and uses thereof
HK1213151A1 (en) Xanthophyll compositions and methods of use
EP2852370A4 (en) Radiance compositions and methods of use
EP2741762A4 (en) Natriuretic peptide compositions and methods of preparation
IL234228B (en) Compositions of glp-1 peptides and preparation thereof
HK1212998A1 (en) Ron compositions and methods of use thereof ron
GB201219884D0 (en) New composition and preparation thereof
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same
EP2841164A4 (en) Dermal-appropriate compositions and methods of use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed